Minnesota accuses insulin makers of deceptive drug pricing

Oct 16 (Reuters) - Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively raising prices for insulin.

In a lawsuit filed in federal court in Trenton, New Jersey, Minnesota Attorney General Lori Swanson took aim at the companies after the list price for some insulin products more than tripled since 2002. (Reporting by Nate Raymond in Boston; Editing by David Gregorio)